Assembly Biosciences

ASMB62

$16.20arrow_drop_down4.98%-$0.85

ASMB62

$16.20

arrow_drop_down4.98%-$0.85

Performance History

Key Stats
Open	$17.05
Prev. Close	$17.05
EPS	-8.69
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$102.41M
PE Ratio	-

	LOW	HIGH
Day Range	16.10	17.05
52 Week Range	7.68	20.04

Ratios







EPS	-8.69

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Assembly Biosciences (ASMB)

Assembly Biosciences Inc (ASMB) is a biotechnology company that focuses on the development of innovative treatments for hepatitis B virus (HBV) and other viral infections. The company is dedicated to addressing the unmet medical needs of patients by advancing a pipeline of potential therapeutics. ASMB is committed to applying its expertise in microbiome biology to develop novel, orally-administered drugs that target viral infections.

The stock price history of Assembly Biosciences Inc (ASMB) reflects the company's progress and potential. Investors have closely followed the company's journey, as ASMB has made significant advancements in its research and development efforts. The stock price has fluctuated over time, influenced by market conditions, industry developments, and company-specific news.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Jason A. Okazaki
Headquarters: South San Francisco
Employees: 70
Exchange: NASDAQ

Keep an eye on Assembly Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Assembly Biosciences 's (ASMB) price per share?

The current price per share for Assembly Biosciences (ASMB) is $16.2. The stock has seen a price change of -$0.85 recently, indicating a -4.99% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Assembly Biosciences (ASMB)?

For Assembly Biosciences (ASMB), the 52-week high is $20.04, which is 23.7% from the current price. The 52-week low is $7.68, the current price is 110.94% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Assembly Biosciences (ASMB) a growth stock?

Assembly Biosciences (ASMB) has shown an average price growth of -6.65% over the past three years. It has received a score of 99 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Assembly Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Assembly Biosciences (ASMB) stock price performance year to date (YTD)?

As of the latest data, Assembly Biosciences (ASMB) has a year-to-date price change of 62.26%. Over the past month, the stock has experienced a price change of -7.9%. Over the last three months, the change has been 13.29%. Over the past six months, the figure is 10.05%. Looking at a longer horizon, the five-year price change stands at -89.77%.

help

Is Assembly Biosciences (ASMB) a profitable company?

Assembly Biosciences (ASMB) has a net income of -$61.23M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -143.01% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $7.16M, although specific revenue growth data is currently not available. Operating income is noted at -$64.65M. Furthermore, the EBITDA is -$50.27M.

help

What is the market capitalization of Assembly Biosciences (ASMB)?

Assembly Biosciences (ASMB) has a market capitalization of $102.42M. The average daily trading volume is 16.36, indicating the stock's liquidity and investor engagement.